SUMMARY Plasma phosphate values are significantly lower in spontaneously hypertensive rats (SHR) than in normotensive Wistar-Kyoto rats (WKY). In this study, we increased plasma phosphate in SHR by a high dietary phosphate intake and followed the effects on blood pressure. Fifteen male WKY and 15 male SHR were housed from 4 weeks of age up to 26 weeks. At 4 weeks of age all SHR manifested a hypophosphatemia compared with age-matched WKY (F= 62, p<0.0003). At 5 weeks of age, the rats were divided into three diet groups: a control group, a group receiving 1.41% (wt/vol) KCI in drinking water, and a group receiving 2% (wt/vol) K 2 HPO 4 KH 2 PO 4 in drinking water. In the control (F=16.2, p<0.02) and KCI groups, (F=36.3, p<0.03), hypophosphatemia persisted throughout the study. The phosphate-supplemented diet normalized plasma phosphate level in SHR but did not change plasma phosphate level in WKY. As a consequence, no difference in plasma phosphate level between WKY and SHR was present in the group receiving additional phosphate from that time on (F= 1.2, p>0.41). The phosphate-supplemented diet significantly decreased systolic blood pressure in both strains. In phosphate-supplemented SHR, a significant decline in systolic blood pressure was observed from 20 weeks of age on (at 20 weeks of age: 222 ± 3 mm Hg for control SHR vs 198 ± 5 nun Hg for phosphate-supplemented SHR; p < 0.0003). In phosphate-supplemented WKY, a slight but significant decrease hi systolic blood pressure was observed from 24 weeks of age on (at 25 weeks of age: 133 ± 1 mm Hg for control WKY vs 125 ± 1 mm Hg for phosphate-supplemented WKY; p<0.0004). The KCI diet had no significant effect on systolic blood pressure in either strain. Plasma electrolyte (sodium, potassium, calcium, and magnesium) levels were not influenced by the two diets throughout the study. We conclude that a high dietary phosphate intake, with concomitant normalization of hypophosphatemia, results in a decrease in blood pressure in SHR. The phosphate-induced hypotensive effect was not apparent until 15 weeks after initiation of the diet. The mechanism behind this effect remains to be elucidated. (Hypertension 9: 96-102, 1987 Epidemiological and clinical data suggest that phosphate metabolism is altered in human hypertension as well. Plasma phosphate has been shown to be lower in Received November 15, 1985; accepted August 8, 1986. patients with essential hypertension. 4 In hyperparathyroidism associated with hypertension, serum phosphate was significantly lower than in hyperparathyroidism in normotensive subjects. 3 An association between lower intakes of phosphorus and a greater risk of being hypertensive has been observed. 6 Moreover, in normotensive subjects plasma phosphate levels were inversely related to blood pressure, 7 suggesting that a decrease in plasma phosphate could be associated with an increase in blood pressure. In contrast, Lau et al. 8 recently suggested that phosphate deficiency mediates the antihypertensive effect of a high calcium diet in SHR. Their findings associate phosphate depletion with hypotensive rather than with hypertensive actions.
patients with essential hypertension. 4 In hyperparathyroidism associated with hypertension, serum phosphate was significantly lower than in hyperparathyroidism in normotensive subjects. 3 An association between lower intakes of phosphorus and a greater risk of being hypertensive has been observed. 6 Moreover, in normotensive subjects plasma phosphate levels were inversely related to blood pressure, 7 suggesting that a decrease in plasma phosphate could be associated with an increase in blood pressure. In contrast, Lau et al. 8 recently suggested that phosphate deficiency mediates the antihypertensive effect of a high calcium diet in SHR. Their findings associate phosphate depletion with hypotensive rather than with hypertensive actions.
It is unknown whether disturbances in phosphate metabolism play a role in the initiation and maintenance of hypertension. Therefore, we studied the ef-
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fects of long-terra normalization of plasma phosphate on blood pressure and phosphate metabolism in SHR using normotensive Wistar-Kyoto rats (WKY) as a control.
Materials and Methods
Fifteen 4-week-old WKY and fifteen 4-week-old SHR (TNO, Zeist, The Netherlands) were housed in groups of four under controlled temperature, light exposure, and humidity. All animals were provided food containing 1.06% (wt/wt) calcium, 0.84% (wt/wt) phosphorus, 0.40% (wt/wt) sodium, and 0.63% (wt/wt) potassium (RHM-TM; Hope Farms, Woerden, The Netherlands) and tap water ad libitum. At 5 weeks of age, the rats were individually housed and divided into three diet groups: a control group, a group receiving 1.41% (wt/vol) KCI in the drinking water
Results

Body Weights
The WKY and SHR in the three diet groups were housed from 4 weeks of age to 26 weeks of age. Body weight was measured in each rat from the age of 6 weeks, and the mean values are shown in Figure 1 . Among the WKY there was no significant difference in body weight during the study. In the KPi group of SHR body weight increased significantly from Week 21 on.
The mean daily food and water consumptions for the diet groups are given in Table 1 . No difference in daily food consumption could be detected. The KCI group drank more water than the control group in both rat strains, suggesting that KCI in the drinking water increases thirst sensation in rats. The KPi diet significantly increased the water intake in SHR but not in WKY. This is an interesting observation in view of the hypophosphatemia in SHR.
Balance Studies
The phosphate, potassium, and calcium balance in the diet groups was compared, as shown in Table 2 . Phosphate balance of the control and KCI groups was equal for both rat strains. Only the WKY and SHR on the KPi diet absorbed more phosphate. Presumably, the rats adapted to the KPi diet, since at 12 weeks of Plasma sodium, potassium, calcium, and magnesium levels in WKY and SHR are given in Table 3 . As can be seen, the diets had no effects on plasma electrolytes in either strain.
Blood Pressure
At 9 weeks of age, mean systolic blood pressure was already higher in SHR than in WKY (Figure 3 ), regardless of the diet group. In SHR on KPi diet, a significant decline in systolic blood pressure was observed from 20 weeks of age on and averaged 25 mm Hg. In addition, in WKY on KPi diet, a slight but significant decrease was observed from 24 weeks of age on. The KCl diet had no influence on systolic blood pressure in WKY and SHR when compared with the control diet.
Discussion
The results of the present study confirm that phosphate metabolism is disturbed in SHR. Normalization of the main defect (i.e., hypophosphatemia) by a high dietary phosphate intake was accompanied by a decrease in blood pressure in SHR. However, the hypotensive effect of a high phosphate intake was not apparent until 15 weeks after initiation of the diet or 10 Values are means ± SEM. Number of rats used in each group is five. The statistical significance between control and KCl group with respect to KPi group was determined by multivanate analysis and expressed as F value and associated probability (p). weeks after normalizing plasma phosphate level. In addition, high dietary phosphate reduced blood pressure without altering plasma phosphate level in WKY. These observations suggest that hypophosphatemia and hypertension in SHR are not related in a simple causal way.
In most reports on modification of dietary intake and effects on blood pressure, the development and maintenance of hypertension in SHR could be decelerated but not arrested. For instance, correcting ionized calcium levels in SHR by a high calcium intake beginning at 12 weeks of age elicited a hypotensive effect of approximately 30 mm Hg 24 weeks after the start of the high calcium diet. 10 In a subsequent study by the same group, the calcium diet was administered as early as 4 weeks of age and the blood pressure reduction was observed from 20 weeks of age on." Elevation of dietary magnesium affected the course of hypertension in SHR by a maximum of 30 mm Hg, but it did not prevent the development of hypertension. l2 The intake of a tenfold higher amount of potassium than normal caused a fall in systolic blood pressure of 34 mm Hg in SHR. 13 The order of magnitude by which these diets affected blood pressure is comparable to that found in our study, in which blood pressure was reduced by 25 mm Hg. The difference is that the hypotensive effects of high magnesium or potassium intake are evident in a few weeks, whereas a few months are required for the effects of high phosphate or calcium intake to become manifest. All these studies, which attempted to compensate for defects, provide evidence for a multifactorial etiology in the development and maintenance of hypertension in SHR.
The KPi diet increased plasma phosphate in SHR, suggesting a correctable hypophosphatemia. It seems PHOSPHATE DIET AND BLOOD PRESSURE IN SHRJBindels et al. Ago {weeks)
FIGURE 3. Systolic blood pressure of the WKY and SHR as a function of age and diet. Asterisk indicates a significant difference (p<0.05) between the KPi and control group as well as between the KPi and KCI group.
possible that primary phosphate malabsorption by the intestine in SHR might induce hypophosphatemia that could then be overcome by a high phosphate diet. However, whether or not intestinal phosphate absorption is suppressed in SHR has not been investigated. Defective intestinal absorption in SHR is at least controversial, since calcium absorption in the duodenum of aging SHR has been reported to be higher, 14 ' li unaltered, 16 and lower. "• 18 However, a recent report points to decreased duodenal calcium absorption in SHR. McCarron et al., 18 using the Ussing chamber technique, showed a reduction in net duodenal calcium flux in SHR. Schedl et al. l7 used both everted duodenal sacs in vitro and in situ duodenal luminal perfusion and showed a profound reduction in maximal duodenal transport of calcium. Lau et al.
14 reported a mild calcium malabsorption in 10-week-old SHR, as assessed by balance studies. In the same study, however, the adult SHR were characterized by increased calcium retention induced by primary hyperabsorption. It is difficult to relate these findings to intestinal phosphate absorption, since the jejunum, and not the duodenum, is the main site of phosphate absorption in the intestine."
An interesting observation in the present study was that addition of phosphate to the drinking water induced a higher water intake in SHR than in the control, as if the rats unconsciously wanted to compensate for their hypophosphatemia.
The KCI diet served as a control for the concomitant high potassium intake in the KPi group. The KCI diet did not affect either the blood pressure or the plasma electrolytes, thus excluding an effect of high potassium intake on blood pressure. This finding contrasts with the observation that a high potassium intake in human and animal hypertension lowers blood pressure. 20 In studies in which a high potassium intake lowered blood pressure, plasma potassium concentration always increased, although modestly. For instance, increasing plasma potassium by 0.4 mM decreased blood pressure by 16 mm Hg in SHR. 21 In another study, a tenfold increase in dietary potassium was used to lower blood pressure in hypertensive rats. 13 In our study potassium intake increased fourfold and did not result in an increase in plasma potassium, which may explain the lack of an effect on blood pressure of the high potassium intake in our study.
Various mechanisms could be responsible for the hypotensive action of a high phosphate diet. Phosphate is a prerequisite for energy-requiring processes in every cell and could therefore influence vascular contractility. Long-term phosphate depletion has been shown to decrease the phosphate and adenosine 5'-triphosphate (ATP) content of mesenteric vessels. 22 In contrast, hypophosphatemia induced by respiratory alkalosis was associated in rats with increased phosphate uptake by muscle and liver. 23 No data on vascular phosphate and ATP content in SHR are available so far. In normotensive rats, severe phosphate depletion is associated with a decrease in blood pressure that is due mainly to myocardial dysfunction and an impaired responsiveness of blood vessels to pressure agonists. 22 In contrast, in SHR hypophosphatemia is associated with increased blood pressure; therefore, other mechanisms must be involved. The blood pressure-reducing effect of high phosphate diets is not limited to the pathological situation of hypertension and occurred also in the control WKY. This observation suggests that a mechanism other than normalization of plasma phosphate must be involved.
A recent study has shown that parenterally administered phosphate blocks the antihypertensive effect of a high calcium intake, presumably through correction of calcium-induced phosphate deficiency. 8 Our findings do not support this hypothesis. The reasons for the discrepancy in results are not clear, although methodological variations could be involved (e.g., orally versus parenterally applied phosphate). McCarron et al. , 18 applying a 2% calcium diet instead of the 4.3% calcium diet used by Lau et al., 8 noted a reduction in blood pressure with no change in serum phosphate in SHR. This last observation dissociates calcium effects on blood pressure from induced changes in phosphate deficiency. In addition, in our study it took months before the high phosphate diet lowered blood pressure, whereas in the study by Lau et al., 8 parenteral phosphate application changed blood pressure in 2 weeks.
Additional mechanisms to be considered include changes in blood ionized calcium caused by increased phosphate intake. Blood ionized calcium levels were not determined in our study. Increasing phosphate by 1 mM results in a minor decrease in ionized calcium of 0.018 mM, as recently examined in vitro. 24 Since in our study, increases in plasma phosphate resulting from high phosphate intake never exceeded 0.5 mM, a meaningful decrease in ionized calcium can be excluded. Moreover, decreases in blood ionized calcium are associated with hypertension rather than with hypotension. 10 Whether the increased rate of growth in SHR on KPi diet is involved in the hypotensive effect of a high phosphate diet is not clear at the moment.
The current findings could also be of value in relation to human hypertension, since comparable disturbances in phosphate metabolism have been found in human hypertension. 4 
"
6 Further studies are needed to delineate the mechanisms involved in the hypotensive effect of high phosphate intake.
